We demonstrated that overexpression of the TRIM47 protein predicted poor prognosis in ER-positive breast cancer patients, and that overexpression of TRIM47 caused endocrine-therapy-resistant growth in breast cancer cell lines [5]. Here, TRIM47 is linked to breast cancer.